These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 8852167

  • 1. Gaucher disease: an overview of clinical characteristics and therapy.
    Kingma W.
    J Intraven Nurs; 1996; 19(2):79-82. PubMed ID: 8852167
    [Abstract] [Full Text] [Related]

  • 2. [Diagnosis and treatment of Gaucher disease in Croatia].
    Mrsić M.
    Lijec Vjesn; 2007 May; 129 Suppl 3():38-42. PubMed ID: 18959062
    [Abstract] [Full Text] [Related]

  • 3. [Gaucher disease: clinical, genetic and therapeutic aspects].
    Germain DP.
    Pathol Biol (Paris); 2004 Jul; 52(6):343-50. PubMed ID: 15261378
    [Abstract] [Full Text] [Related]

  • 4. Gaucher disease, enzyme replacement therapy, and the Patient Assistance Program.
    Goldwater RS.
    J Intraven Nurs; 1996 Jul; 19(2):83-8. PubMed ID: 8852168
    [Abstract] [Full Text] [Related]

  • 5. Velaglucerase alfa, a human recombinant glucocerebrosidase enzyme replacement therapy for type 1 Gaucher disease.
    Pastores GM.
    Curr Opin Investig Drugs; 2010 Apr; 11(4):472-8. PubMed ID: 20336596
    [Abstract] [Full Text] [Related]

  • 6. Gaucher's disease: a review for the internist and hepatologist.
    Niederau C, Häussinger D.
    Hepatogastroenterology; 2000 Apr; 47(34):984-97. PubMed ID: 11020862
    [Abstract] [Full Text] [Related]

  • 7. Individualization of long-term enzyme replacement therapy for Gaucher disease.
    Andersson HC, Charrow J, Kaplan P, Mistry P, Pastores GM, Prakash-Cheng A, Rosenbloom BE, Scott CR, Wappner RS, Weinreb NJ, International Collaborative Gaucher Group U.S. Regional Coordinators.
    Genet Med; 2005 Feb; 7(2):105-10. PubMed ID: 15714077
    [Abstract] [Full Text] [Related]

  • 8. [French results of enzyme replacement therapy in Gaucher's disease].
    Schaison G, Caubel I, Belmatoug N, Billette de Villemeur T, Saudubray JM.
    Bull Acad Natl Med; 2002 Feb; 186(5):851-61; discussion 861-3. PubMed ID: 12412377
    [Abstract] [Full Text] [Related]

  • 9. Gaucher disease: from fundamental research to effective therapeutic interventions.
    de Fost M, Aerts JM, Hollak CE.
    Neth J Med; 2003 Jan; 61(1):3-8. PubMed ID: 12688562
    [Abstract] [Full Text] [Related]

  • 10. Hydrophilic iminosugar active-site-specific chaperones increase residual glucocerebrosidase activity in fibroblasts from Gaucher patients.
    Chang HH, Asano N, Ishii S, Ichikawa Y, Fan JQ.
    FEBS J; 2006 Sep; 273(17):4082-92. PubMed ID: 16934036
    [Abstract] [Full Text] [Related]

  • 11. Miscellaneous non-inflammatory musculoskeletal conditions. Gaucher disease and bone.
    Mikosch P.
    Best Pract Res Clin Rheumatol; 2011 Oct; 25(5):665-81. PubMed ID: 22142746
    [Abstract] [Full Text] [Related]

  • 12. [Gene therapy of Gaucher's and Fabry's diseases: current status and prospects].
    Fabrega S, Lehn P.
    J Soc Biol; 2002 Oct; 196(2):175-81. PubMed ID: 12360746
    [Abstract] [Full Text] [Related]

  • 13. Phenotypic and genotypic heterogeneity in Gaucher disease type 1: a comparison between Brazil and the rest of the world.
    Sobreira E, Pires RF, Cizmarik M, Grabowski GA.
    Mol Genet Metab; 2007 Jan; 90(1):81-6. PubMed ID: 16996765
    [Abstract] [Full Text] [Related]

  • 14. The role of neurogenetics in Gaucher disease.
    Brady RO, Barton NW, Grabowski GA.
    Arch Neurol; 1993 Nov; 50(11):1212-24. PubMed ID: 8215980
    [Abstract] [Full Text] [Related]

  • 15. Orthopaedic manifestations of Gaucher disease.
    Lutsky KF, Tejwani NC.
    Bull NYU Hosp Jt Dis; 2007 Nov; 65(1):37-42. PubMed ID: 17539760
    [Abstract] [Full Text] [Related]

  • 16. [Gaucher disease: diagnosis and treatment].
    Fumić K, Stavljenić-Rukavina A, Mrsić M, Potocki K.
    Acta Med Croatica; 2004 Nov; 58(5):353-8. PubMed ID: 15756799
    [Abstract] [Full Text] [Related]

  • 17. [From gene to disease; Gaucher disease].
    Hollak CE, Boot RG, Poorthuis BJ, Aerts JM.
    Ned Tijdschr Geneeskd; 2005 Sep 24; 149(39):2163-6. PubMed ID: 16223076
    [Abstract] [Full Text] [Related]

  • 18. Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources.
    Grabowski GA, Barton NW, Pastores G, Dambrosia JM, Banerjee TK, McKee MA, Parker C, Schiffmann R, Hill SC, Brady RO.
    Ann Intern Med; 1995 Jan 01; 122(1):33-9. PubMed ID: 7985893
    [Abstract] [Full Text] [Related]

  • 19. [Gaucher's disease: pathogenesis, diagnosis and therapy].
    Pregun I, Tulassay Z.
    Orv Hetil; 2004 Sep 12; 145(37):1883-90. PubMed ID: 15493618
    [Abstract] [Full Text] [Related]

  • 20. A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease.
    Di Rocco M, Giona F, Carubbi F, Linari S, Minichilli F, Brady RO, Mariani G, Cappellini MD.
    Haematologica; 2008 Aug 12; 93(8):1211-8. PubMed ID: 18603565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.